Marc Espié

10.6k citations
199 papers · 7.9k · 1 hit paper · h-index 51

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 1%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer-related Molecular Pathways

Papers in

    • Breast Cancer Treatment Studies 87
    • Cancer Treatment and Pharmacology 24
    • HER2/EGFR in Cancer Research 18
    • Cancer Risks and Factors 8

Marc Espié

181 papers receiving 7.7k citations

Marc Espié's Hit Papers

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial 2017 · 415 citations
4150+3+6Years since publication100200300400

Peers

Marc Espié
Comparison fields: 5 of 106
  • Cancer Research 2.7k
  • Oncology 2.3k
  • Radiology, Nuclear Medicine and Imaging 1.8k
  • Pathology and Forensic Medicine 610
  • Pulmonary and Respiratory Medicine 578
Replace Kenjiro Aogi with:
Kenjiro Aogi Japan
Flora Zagouri Greece
Ze-Fei Jiang China
Shaheenah S. Dawood United Arab Emirates
Priya Rastogi United States
Bruno P. Coudert France
Serena Di Cosimo Italy
Anne F. Schott United States
Daniel J. Booser United States
M. Castiglione Switzerland
Marc Espié relative to Kenjiro Aogi Japan Kenjiro Aogi's profile →
Citations per field
00.5×2×2.9×
Kenjiro Aogi · 1×
Citations per year

Countries citing papers authored by Marc Espié

Since Specialization
Citations

This map shows the geographic impact of Marc Espié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Espié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Espié more than expected).

Fields of papers citing papers by Marc Espié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Espié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Espié. The network helps show where Marc Espié may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc Espié, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc Espié Line = papers co-authored together Marc Espié links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2017469
2
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Hit paper breakdown →
2017415
3 2010341
4 1990309
5 2013266
6 2004208
7 2012205
8 2006169
9 2013163
10 2008160
11 2012146
12 1996143
13 2020140
14 2007139
15 2002136
16 2001130
17 2012129
18 2015110
19 1998108
20 2012106

About Marc Espié

Marc Espié is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 199 papers that have together received 7.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (87 papers), Breast Lesions and Carcinomas (26 papers), Cancer Treatment and Pharmacology (24 papers), Medical Imaging Techniques and Applications (23 papers), HER2/EGFR in Cancer Research (18 papers), MRI in cancer diagnosis (8 papers), Cancer Risks and Factors (8 papers) and BRCA gene mutations in cancer (7 papers). The work is most often cited by research in Cancer Research (2.7k citations), Oncology (2.3k citations), Radiology, Nuclear Medicine and Imaging (1.8k citations), Pathology and Forensic Medicine (610 citations) and Pulmonary and Respiratory Medicine (578 citations). Marc Espié has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Michel E. Marty, Sylvie Giacchetti, David Groheux, Elif Hindié, Anne de Roquancourt, Caroline Cuvier, Philippe Bertheau, Laëtitia Vercellino, Anne‐Sophie Hamy and Jacqueline Lehmann‐Che. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, British Journal of Cancer, Journal of Nuclear Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact